Karl-Friedrich Kowalewski
@kfkowalewski
Attending Urologist @UMM_Urology and Head of Junior research group -Intelligent Systems and Robotis in Urology- @DKFZ | Member @EAU_YAUroTech
ID: 734695152854392832
23-05-2016 10:39:09
202 Tweet
394 Takipçi
351 Takip Edilen
Wouldn't you like your surgeon to have trained before performing surgery? Our international survey aims to map and compare the reality of training in minimally invasive and robotic surgery globally. esurvey.uniklinikum-dresden.de/pub/index.php/… Find out more here and participate! SAGES is in Long Beach in 2025!
Very excited to share single surgeon experience with PFS-RARP with over 2 years of followup! Christopher Dall Bradley Mason Eshu Choudhury 🇧🇩🌶 Belén Mora-Garijo Jillian Egan Jim Hu Society of Urologic Oncology Urologic Oncology sciencedirect.com/science/articl… TL;DR: 1. Increased urinary and overall EPIC-CP QOL
Randomized controlled feasibility trial of robot-assisted vs conventional open partial nephrectomy: The #ROBOCOP II study. #BeyondTheAbstract on UroToday > bit.ly/3RRpYWu Karl-Friedrich Kowalewski Urology University Center Mannheim Caelan Haney European Urology Oncology
"Evidence-based medicine in urology" at the #EAU24 🇫🇷 Session based on two Eur Urol Focus series of #EBM articles authored by the faculty - covers key aspects Welcome on Friday April 5 at 14:45 to Purple Area S03 Series 2 x.com/KariTikkinen/s… Series 1 x.com/KariTikkinen/s…
With Matt Galsky #EAU24 adjuvant nivolumab in bladder ca: HR 0.76 in ITT & 0.56 in PD-L1 +ve. Clinically meaningful results especially in PD-L1 +ves. No data on PD-L1-ve! OS is not yet significant but this data is impressive. ~60% relapse and 24% get subsequent IO. ~10% ⬆️tox.
🚨 Breaking results 🚨 PRIME Trial UCL study presented at #EAU24 European Association of Urology (EAU). This 🌍 multicentre trial (n=555, 22 sites) showed that biparametric MRI without contrast is non-inferior 2 multiparametric MRI & should be the new standard for prostate cancer diagnosis if image quality is good
📢📢 YAU UroTech meeting at #EAU24 Lot of ideas and new projects coming up for next year: AI, 3D models, surgery videos storage and analysing 🤓 Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺 Enrico Checcucci Severin Rodler Pietro Piazza Loïc Baekelandt Pieter De Backer
Great connecting with prior European Association of Urology (EAU) Amer. Urol. Assn. scholars and friends Giancarlo Marra Iulia Andras Karl-Friedrich Kowalewski 🇫🇷🍻#EAU24
ENZA-P in The Lancet Oncology Lu-177 PSMA-617 + enzalutamide vs. enza alone: ● ↑PFS: 13.0 vs 7.8, hazard radio 0.43 ● PSA90 response 78% vs 37% ● PSA50 response 93% vs. 68% ● no additional side effects Incredible work from Louise Emmett Ian Davis & ANZUP team
Long-term Prostate Cancer–specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer Read the full article here: buff.ly/3QTtJet Annika Herlemann Matt Cooperberg #UroSoMe #Medtwitter #PCa
Unpopular opinion: puls modulation does not help that much in HoLEP. Check out or recent publication in WJUROL link.springer.com/article/10.100…. What do you think? Austen Slade, MD, MBA Tobias Bothmann Martin Kanne Amy Krambeck Felipe Figueiredo HoLEP 🇧🇷 Thomas RW Herrmann Fernando GomezSancha Joel Funk MD FACS Matthew Lee Karin Lehrich
Standing ovation for Dr Walsh at the 50th anniversary celebration, as he shares pearls from his incredible career The Johns Hopkins Brady Urological Institute Johns Hopkins Medicine 👏
What an awesome surprise! Congratulations to the whole team including the clinical collaborators PD Dr. Felix Nickel Alex and Karl-Friedrich Kowalewski
Die molekularen Mechanismen von Blasenkrebs verstehen. Grundlagenforschung für Patienten erklärt. Eine Kooperation zwischen Urology University Center Mannheim und DKFZ Epigenetics, gefördert vom Hector Seed Funding Programm! Dank an Malin Nientiedt Manuel N Manuel Rodríguez Paredes @filmhochdrei